US 10849912
Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment
granted A61KA61K31/351A61K31/366
Quick answer
US patent 10849912 (Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/351, A61K31/366, A61K31/585, A61K45/06